This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum, Precisis Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Martin Baumann - Innovator in Radiotherapy Technology
Introduction
Martin Baumann is a notable inventor based in Ostringen, Germany. He has made significant contributions to the field of radiotherapy technology, particularly through his innovative designs in multi-leaf collimators. His work focuses on enhancing the precision and efficiency of radiation therapy, which is crucial for effective cancer treatment.
Latest Patents
Martin Baumann holds a patent for a leaf module designed for a multi-leaf collimator. This invention, which is particularly suitable for Cobalt-60 or mid- to low-end linac radiotherapy apparatuses, comprises a leaf unit and a leaf drive unit. The leaf unit is designed to shield beams from a selected area and is mounted displaceably in an adjusting direction. The leaf drive unit enables linear displacement of the leaf unit through pneumatic actuation. This design aims to achieve compactness while ensuring simple, reliable, and variable adjustability of the leaf unit.
Career Highlights
Throughout his career, Martin Baumann has worked with prominent organizations such as Precisis AG and the Deutsches Krebsforschungszentrum. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in cancer treatment technologies.
Collaborations
Some of Martin Baumann's notable coworkers include Armin Runz and Gernot Echner. Their collaborative efforts have furthered the development of innovative solutions in radiotherapy.
Conclusion
Martin Baumann's contributions to the field of radiotherapy through his patented inventions demonstrate his commitment to improving cancer treatment technologies. His work continues to influence the industry and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile